Ayurvedic Intervention for Fallopian Tube Blockage in the form of medicated oil through intra-uterine instillation and its effect on Uterine Endometrium

A Comparative Clinical Study of Lashuna Taila and Shatapushpa taila Uttarabasti in the Management of Fallopian Tube Blockage and Endometrial Receptivity - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/074866

Enrollment

Registered

2024-10-07

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N971- Female infertility of tubal origin

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients of child-bearing age (20-40years) with active marital life of 1 year or more. Having complaint of failure to conceive with one/both fallopian tube blocked. Tubal Blockage Diagnosed by H.S.G./S.S.G./Laparoscopy. Patients having primary and secondary infertility both will be included.

Exclusion criteria

Exclusion criteria: Patients having age group below 20 years & above 40 years. Patients having any acute pelvic infection, Congenital anomalies of vulva, vagina, cervix, uterus and fallopian tube. Malignancy of genital tract. Any previous surgical operation of cervix which leads difficulty in procedure. HIV, HBsAg, Anti- HCV positive patients and history of Active Genital herpes. Patients having Sexually Transmitted Disease. Patients having active Vulvo-vaginitis. Patients with history of systemic diseases like Hypertension, Diabetes mellitus, Congestive cardiac failure etc. Patients with Coagulopathic disorders. Patients with history of recent abortion. Patients with active genital tuberculosis. Bleeding from the cervical polyp, cervical fibroid and cervical erosion. IUCD in utero, pelvic endometriosis. Any obvious pelvic pathology like fibroid uterus and Adenomyosis etc.

Design outcomes

Primary

Measure	Time frame
To evaluate the clinical efficacy of Lashuna taila and Shatapushpa taila Uttarabasti in the Management of Fallopian Tube Blockage and Endometrial receptivityTimepoint: 4 months	—

Secondary

Measure	Time frame
patency of fallopian tubeTimepoint: 4 months	—

Countries

India

Contacts

Public ContactDr Stuti Sharma

Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University

ssom18@gmail.com7607165096

Outcome results